Table of Contents

1. Introduction
 1.1 Market Definition & Scope
 1.2 Research Assumptions & Abbreviations
 1.3 Research Methodology

2. Executive Summary
 2.1 Market Snapshot
 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022 – 2035
 2.3 Market Size & Forecast, By Segmentation, 2022 – 2035
  2.3.1 Market Size By Treatment
  2.3.2 Market Size By Procedure
  2.3.3 Market Size By Product
  2.3.4 Market Size By End-use
 2.4 Market Share & Bps Analysis By Region, 2025
 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
 2.6 Industry CxO’s Perspective

3. Market Overview
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Key Market Trends
 3.2 Industry PESTLE Analysis
 3.3 Key Industry Forces (Porter’s) Impacting Market Growth
 3.4 Industry Supply Chain Analysis
  3.4.1 Raw Material/Component Suppliers
  3.4.2 Product Manufacturers
  3.4.3 Distributors/Suppliers
  3.4.4 End-Users (Hospitals, Specialty Clinics)
 3.5 Industry Life Cycle Assessment
 3.6 Parent Market Overview (Urological Devices/Therapeutics)
 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting
 4.1 Pricing Analysis & Reimbursement Landscape
  4.1.1 Overview
  4.1.2 Average Cost Per Procedure: MIPs vs. Invasive Surgery
  4.1.3 Reimbursement Scenario Analysis (CMS, Private Payers) for Key Procedures
  4.1.4 Price Benchmarking of Disposables vs. Capital Equipment
  4.1.5 Impact of Out-of-Pocket Expenditure on Treatment Choice
 4.2 Regulatory & Approval Landscape
  4.2.1 Overview
  4.2.2 FDA 510(k) vs. PMA Approvals for New BPH Devices
  4.2.3 Regional Regulatory Hurdles and Harmonization Efforts (CE Mark, NMPA)
  4.2.4 Compliance with Clinical Trial Guidelines for Novel Energy-Based Therapies
  4.2.5 Future Regulatory Outlook: AI-Assisted & Robotic Procedure Approvals
 4.3 Procedure Adoption & Technology Penetration Metrics
  4.3.1 Overview
  4.3.2 Annual Procedure Volume by Type (e.g., TURP, Laser, PUL, Water Vapor)
  4.3.3 Technology Penetration Rate (%) in Ambulatory Surgical Centers vs. Hospitals
  4.3.4 Patient Preference Shift: Minimally Invasive vs. Traditional Surgical Rates
  4.3.5 Complication & Readmission Rate Statistics by Procedure Type
 4.4 Pipeline & Innovation Metrics
  4.4.1 Overview
  4.4.2 Number of New Devices/Technologies in Clinical Trials (Pivotal Studies)
  4.4.3 Average R&D Investment & Time-to-Market for New BPH Technologies
  4.4.4 Success Rate of Novel Mechanisms (e.g., Aquablation, HIFU, Embolization)
  4.4.5 IP Landscape: Number of Patents Filed/Granted by Technology Type

5. Benign Prostatic Hyperplasia Treatment Market Segmental Analysis & Forecast, By Treatment, 2022 – 2035, Value (USD Million)
 5.1 Introduction
 5.2 Minimal Invasive Surgery
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2035
 5.3 Invasive Surgery

6. Benign Prostatic Hyperplasia Treatment Market Segmental Analysis & Forecast, By Procedure, 2022 – 2035, Value (USD Million)
 6.1 Introduction
 6.2 Transurethral Resection of the Prostate (TURP)
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022 – 2035
 6.3 Prostate Laser Surgery
 6.4 Transurethral Microwave Thermotherapy (TUMT)
 6.5 Transurethral Needle Ablation of the Prostate (TUNA)
 6.6 Prostatic Urethral Lift (PUL)
 6.7 Water Vapor Therapy (Rezūm)
 6.8 Robot-Assisted Laparoscopic Prostatectomy
 6.9 Aquablation Therapy
 6.10 Prostatic Artery Embolization (PAE)
 6.11 Open Prostatectomy
 6.12 Bipolar Enucleation of Prostate
 6.13 Transurethral Incision of the Prostate (TUIP)
 6.14 High-Intensity Focused Ultrasound (HIFU)

7. Benign Prostatic Hyperplasia Treatment Market Segmental Analysis & Forecast, By Product, 2022 – 2035, Value (USD Million)
 7.1 Introduction
 7.2 Resectoscopes
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022 – 2035
 7.3 Urology Lasers
 7.4 Radiofrequency Ablation Devices
 7.5 Electrodes
 7.6 Catheters
 7.7 Prostatic Stents
 7.8 Implants
 7.9 Others

8. Benign Prostatic Hyperplasia Treatment Market Segmental Analysis & Forecast, By End-use, 2022 – 2035, Value (USD Million)
 8.1 Introduction
 8.2 Hospitals
  8.2.1 Key Trends
  8.2.2 Market Size & Forecast, 2022 – 2035
 8.3 Specialty Facilities
 8.4 Research and Manufacturing

9. Benign Prostatic Hyperplasia Treatment Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Million)
 9.1 Introduction
 9.2 North America
  9.2.1 Key Trends
  9.2.2 Market Size & Forecast, By Treatment, 2022 – 2035
  9.2.3 Market Size & Forecast, By Procedure, 2022 – 2035
  9.2.4 Market Size & Forecast, By Product, 2022 – 2035
  9.2.5 Market Size & Forecast, By End-use, 2022 – 2035
  9.2.6 Market Size & Forecast, By Country, 2022 – 2035
   9.2.6.1 USA
   9.2.6.2 Canada
 9.3 Europe
  9.3.1 Key Trends
  9.3.2 Market Size & Forecast, By Treatment, 2022 – 2035
  9.3.3 Market Size & Forecast, By Procedure, 2022 – 2035
  9.3.4 Market Size & Forecast, By Product, 2022 – 2035
  9.3.5 Market Size & Forecast, By End-use, 2022 – 2035
  9.3.6 Market Size & Forecast, By Country, 2022 – 2035
   9.3.6.1 Germany
   9.3.6.2 UK
   9.3.6.3 France
   9.3.6.4 Italy
   9.3.6.5 Spain
   9.3.6.6 Russia
   9.3.6.7 Poland
   9.3.6.8 Rest of Europe
 9.4 Asia-Pacific
  9.4.1 Key Trends
  9.4.2 Market Size & Forecast, By Treatment, 2022 – 2035
  9.4.3 Market Size & Forecast, By Procedure, 2022 – 2035
  9.4.4 Market Size & Forecast, By Product, 2022 – 2035
  9.4.5 Market Size & Forecast, By End-use, 2022 – 2035
  9.4.6 Market Size & Forecast, By Country, 2022 – 2035
   9.4.6.1 China
   9.4.6.2 India
   9.4.6.3 Japan
   9.4.6.4 South Korea
   9.4.6.5 Australia
   9.4.6.6 ASEAN Countries
   9.4.6.7 Rest of Asia-Pacific
 9.5 Latin America
  9.5.1 Key Trends
  9.5.2 Market Size & Forecast, By Treatment, 2022 – 2035
  9.5.3 Market Size & Forecast, By Procedure, 2022 – 2035
  9.5.4 Market Size & Forecast, By Product, 2022 – 2035
  9.5.5 Market Size & Forecast, By End-use, 2022 – 2035
  9.5.6 Market Size & Forecast, By Country, 2022 – 2035
   9.5.6.1 Brazil
   9.5.6.2 Argentina
   9.5.6.3 Mexico
   9.5.6.4 Colombia
   9.5.6.5 Rest of Latin America
 9.6 Middle East & Africa
  9.6.1 Key Trends
  9.6.2 Market Size & Forecast, By Treatment, 2022 – 2035
  9.6.3 Market Size & Forecast, By Procedure, 2022 – 2035
  9.6.4 Market Size & Forecast, By Product, 2022 – 2035
  9.6.5 Market Size & Forecast, By End-use, 2022 – 2035
  9.6.6 Market Size & Forecast, By Country, 2022 – 2035
   9.6.6.1 UAE
   9.6.6.2 Saudi Arabia
   9.6.6.3 Qatar
   9.6.6.4 Egypt
   9.6.6.5 South Africa
   9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape
 10.1 Key Players' Positioning
 10.2 Competitive Developments
  10.2.1 Key Strategies Adopted (%), By Key Players, 2025
  10.2.2 Year-Wise Strategies & Development, 2025 – 2025
  10.2.3 Number Of Strategies Adopted By Key Players, 2025
 10.3 Market Share Analysis, 2024
 10.4 Product/Service & Application Benchmarking
  10.4.1 Product/Service Specifications & Features By Key Players
  10.4.2 Product/Service Heatmap By Key Players
  10.4.3 Application Heatmap By Key Players
 10.5 Industry Start-Up & Innovation Landscape
 10.6 Key Company Profiles
  10.6.1 Boston Scientific Corporation
   10.6.1.1 Company Overview & Snapshot
   10.6.1.2 Product/Service Portfolio
   10.6.1.3 Key Company Financials
   10.6.1.4 SWOT Analysis
  10.6.2 PROCEPT BioRobotics Corporation
  10.6.3 Teleflex Incorporated
  10.6.4 Olympus Corporation
  10.6.5 KARL STORZ SE & Co. KG
  10.6.6 Lumenis Ltd.
  10.6.7 Medtronic plc
  10.6.8 Stryker Corporation
  10.6.9 Cook Medical
  10.6.10 Coloplast Group
  10.6.11 Richard Wolf GmbH
  10.6.12 Dornier MedTech
  10.6.13 Biolitec AG
  10.6.14 Urologix LLC
  10.6.15 Asahi Kasei Corporation
  10.6.16 B. Braun Melsungen AG
  10.6.17 Urotronic Inc.
  10.6.18 OmniGuide Inc.
  10.6.19 Medifocus Inc.
  10.6.20 ProArc Medical Ltd.
  10.6.21 Merit Medical Systems
  10.6.22 Quanta System S.p.A.
  10.6.23 Convergent Laser Technologies
  10.6.24 Prostalund Operations AB

11. Analyst Recommendations
 11.1 SNS Insider Opportunity Map
 11.2 Industry Low-Hanging Fruit Assessment
 11.3 Market Entry & Growth Strategy
 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix
 14.1 List Of Tables
 14.2 List Of Figures